openPR Logo
Press release

Topical Drug Delivery Market Deep Research Report with Forecast to 2031

02-16-2024 12:22 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Insightace analytic

Topical Drug Delivery Market Deep Research Report with Forecast

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Topical Drug Delivery Market Size, Share & Trends Analysis Report By Type (Semi-solids (Creams, Gels, Lotions), Solids (Suppositories), Liquids (Solutions), Transdermal Products), Route (Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres), Region, Market Outlook And Industry Analysis 2031"

The global Topical Drug Delivery Market is estimated to reach over USD 418.70 billion by 2031, exhibiting a CAGR of 8.1% during the forecast period.

Request for Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/2081

Topical drugs are the opposite of systemic medications and products in that they are typically administered to the skin or mucous membranes of the body. These medicines come in various forms, such as creams, foams, gels, lotions, and ointments. The high prevalence of skin conditions and burn injuries, the deep penetration of medications into the body, the growing desire for topical drug administration due to its non-invasive nature, and the rise in the senior population are the leading market drivers for topical drug delivery.

The transdermal delivery of biologics and the acquisition of small market competitors are two factors that are anticipated to present a wide range of prospects for market expansion in the near future. Additionally, the preference for administering medications topically to regulate or extend drug delivery and adopting this method as an alternative to the oral route is anticipated to support market expansion. The system's simplicity of use and the rising demand for self-administered medications also restrain market expansion throughout the projected decade.

List of Prominent Players in the Topical Drug Delivery Market:
• 3M (US)
• AbbVie Inc. (US)
• Bausch Health Companies Inc. (Canada)
• Bayer AG (Germany)
• Boehringer Ingelheim International GmBH (Germany)
• Bristol Myers Squibb (US)
• Cipla (India)
• CMP Pharma, Inc. (Germany)
• Crescita Therpeautics Inc. (Canada)
• Encore Dermatology, Inc. (US)
• Galderma (Switzerland)
• GlaxoSmithKline Plc. (UK)
• Glenmark Pharmaceuticals Ltd. (India)
• Hisamitsu Pharmaceuticals Inc. (Japan)
• Johnson & Johnson Private Limited (US)
• Lavipharm (Greece)
• Lead Chemical Co., Ltd. (Japan)
• Merck & Co. Inc.. (Germany)
• Novartis International AG (Switzerland)
• Pfizer Inc. (US)
• Prosolus Inc. (US)
• Purdue Pharma L.P. (US)
• Rusan Pharma Ltd. (India)
• Teva Pharmaceuticals Industries Ltd. (Israel)
• Viatris Inc. (Mylan N.V.) (US)

Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/2081

Market Dynamics:
Drivers-
The majority of consumers of topical medications for in-home care are older individuals. This aspect also raises the demand for medicinal items made for inhalation, topical application, and transdermal absorption. Using a transdermal patch that is simple to self-apply, transdermal drug delivery improves the simplicity of drug administration. It enables patients to administer themselves in an appropriate and painless manner. By shortening hospital stays, this strategy lowers the cost of healthcare. Additionally, using transdermal patches, carers can quickly assess if a patch has been applied securely. The need for transdermal patches will rise as a result, propelling the expansion of topical drug delivery systems.

Challenges:
The administration of medication to the skin's surface or deep within the skin or mucous membrane is referred to as topical drug delivery. Despite being the optimum site for the administration of pharmacological ingredients to produce both local and systemic effects, skin functions as a barrier and hinders the entry of many APIs. Drugs with bigger particle sizes, however, are more difficult to absorb through the skin. When creating pharmacological compounds for topical dermatological therapy, a compound's molecular weight should be less than 500 Dalton to promote skin absorption. These medications have a large molecular weight, which makes them poorly fat-soluble and prevents them from having the desired therapeutic impact. High molecular weight causes a decrease in percutaneous absorption. This is expected to create a pose for the market growth.

Regional Trends:
The North America Topical Drug Delivery Market is expected to register a major market share in terms of revenue and is projected to grow at a high CAGR in the near future. The rising incidence of skin conditions, the launch and approval of novel topical formulations, and funding for the development of topical medications are some of the factors propelling the regional topical drug delivery market. Additionally, the Asia-Pacific region is anticipated to expand significantly during the projected period. The global market for topical medication delivery is anticipated to rise as a result of the aging population, rising healthcare costs and disposable income, and the increased focus of major global pharmaceutical companies on developing nations like China and India.

Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/2081

Recent Developments:
• In July 2022, The Abbreviated New Drug Application (ANDA) for Diclofenac Sodium Topical Gel, 3%, for the topical treatment of actinic keratoses was authorized by the US Food and Drug Administration for Aleor Dermaceuticals, a division of Alembic Pharmaceuticals.

Segmentation of Topical Drug Delivery Market-
By Product-
• Semi-Solid Formulations
o Creams
o Ointments
o Lotions
o Gel
o Pastes
• Liquid Formulations
o Suspensions
o Solutions
• Solid Formulations
o Powders
o Suppositories
• Transdermal Products
o Transdermal Patches
o Transdermal Semi-Solids
By Route of Administration-
• Dermal Drug Delivery
• Ophthalmic Drug Delivery
• Rectal Drug Delivery
• Vaginal Drug Delivery
• Nasal Drug Delivery
By Facility of Use-
• Homecare Settings
• Hospitals & Clinics
• Burn Centers
• Other Facilities
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

For More Information:
https://www.insightaceanalytic.com/report/topical-drug-delivery-market/2081

Corporate Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
loaction icon
Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
email iconinfo@insightaceanalytic.com
call icon
North America:
+1 551 226 6109
Asia:
+91 79 72967118

Contact Us:
Dhanraj Zurange
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Topical Drug Delivery Market Deep Research Report with Forecast to 2031 here

News-ID: 3387778 • Views:

More Releases from Insightace analytic

Digital Pathology Market Report- Expansive Coverage on the Profit Sources
Digital Pathology Market Report- Expansive Coverage on the Profit Sources
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Pathology Market Size, Share & Trends Analysis Report By Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma, Academia, Hospitals)- Market Outlook And Industry Analysis 2031" The global digital pathology market is estimated to reach over USD 2731.95 million by 2031, exhibiting a CAGR of 12.91%
Digital Health Market Future Trends and Scope Analysis Report
Digital Health Market Future Trends and Scope Analysis Report
Digital Health Market Size, Share & Trends Analysis Report By Technology (Tele-healthcare, mHealth, Healthcare Analytics, Digital Health Systems), By Component (Software, Hardware, Services), By Region, And Segment Forecasts, 2024-2031 "Digital Health Market" in terms of revenue was estimated to be worth $248.58 billion in 2023 and is poised to reach $1,004.03 billion by 2031, growing at a CAGR of 19.56% from 2023 to 2031, according to a new report by
Digital Diabetes Management Market Report on the Untapped Growth Opportunities in the Industry
Digital Diabetes Management Market Report on the Untapped Growth Opportunities i …
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Diabetes Management Market - (By Devices (Smart Glucose Meters, Continuous Glucose Monitoring Systems, And Smart Insulin Pens, Smart Insulin Pumps/ Closed-Loop Pumps & Smart Insulin Patches), Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps), Data Management Software & Platforms And Services), By Device Type (Handheld And Wearable Devices), By End-User(Self/Home Healthcare, Hospitals
Data Center Liquid Cooling Market Exclusive Trends Analysis with Forecast to 2031
Data Center Liquid Cooling Market Exclusive Trends Analysis with Forecast to 203 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Data Center Liquid Cooling Market Size, Share & Trends Analysis Report By End-User Industry (Financial Services And Insurance (BFSI), Banking, IT And Telecom, Government And Public Sector, Manufacturing, Healthcare, Retail), Data Center (Hyperscale, Colocation, Enterprise) And Solution (Indirect & Direct Cooling)- Market Outlook And Industry Analysis 2031" The Global Data Center Liquid Cooling Market is estimated

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug